Bone Marrow Transplantation

Overview

Bone marrow transplantation, more accurately called haematopoietic stem cell transplantation, replaces diseased or damaged blood-forming stem cells with healthy ones. These stem cells live in the bone marrow and rebuild the blood and immune system, so a transplant can restore healthy blood production after disease or intensive treatment has destroyed it.

The healthy cells may be the patient's own (autologous) or from a matched donor (allogeneic), and today they are most often collected from the bloodstream rather than from the bone. It is an established, evidence-based treatment for a range of blood cancers and blood disorders.

For patients facing long waits or high costs at home, accredited transplant centres — some abroad — offer these treatments. This page is an educational overview only — it is not medical advice, and no outcome can be guaranteed. Be wary of clinics marketing unproven "stem cell cures" for unrelated conditions.

Who May Need This

A bone marrow transplant may be part of treatment for certain blood cancers — such as leukaemia, lymphoma, and myeloma — and for some non-cancer conditions, including aplastic anaemia, inherited disorders such as thalassaemia and sickle cell disease, and some immune deficiencies.

Whether a transplant is appropriate depends on the exact diagnosis, disease stage, response to earlier treatment, age, general health, and the availability of a suitable donor. Eligibility is determined by a haematology-transplant team after detailed assessment, and not everyone with these conditions needs or can safely have a transplant.

When It May Be Recommended

A transplant may be recommended when it offers the best chance of controlling or curing a blood disorder — for example after initial chemotherapy for certain leukaemias or lymphomas, or for severe inherited blood disorders where a donor transplant can be curative. Autologous transplants often allow higher-dose treatment by "rescuing" the marrow afterwards.

The decision weighs the potential benefit against the significant risks of the procedure and the intensive treatment involved, and considers alternatives. The final recommendation always depends on individual evaluation by the specialist team.

Diagnosis and Evaluation

Evaluation includes confirming and staging the underlying disease with blood tests, bone marrow examination, and imaging, and assessing the heart, lungs, liver, and kidneys for fitness to withstand intensive treatment. Screening for infection is important because the immune system will be suppressed.

For an allogeneic transplant, tissue (HLA) typing identifies a suitably matched donor — often a sibling or an unrelated volunteer from a registry. Psychological and social assessment and the ability to cope with a demanding, prolonged treatment are also considered, and a second opinion can be valuable.

Treatment Options

Treatment options depend on the disease and may include chemotherapy, radiotherapy, targeted drugs, and immunotherapy, with transplantation used when it offers a better chance of long-term control or cure. The transplant may be autologous (using the patient's own cells) or allogeneic (using donor cells).

Newer cellular therapies such as CAR T-cell treatment are options for some blood cancers in specialist centres. The best strategy depends on the diagnosis, previous treatment, donor availability, and overall health, and your team will explain which options are realistic for you.

How It Is Performed

A transplant is a process rather than an operation. First, stem cells are collected — usually from the bloodstream after medication encourages them out of the marrow, occasionally directly from the bone under anaesthesia. The patient then receives conditioning treatment (chemotherapy, sometimes with radiotherapy) to clear the diseased marrow.

The healthy stem cells are then infused into a vein, much like a blood transfusion, and travel to the bone marrow where they begin to rebuild blood cells over the following weeks (engraftment). Throughout this vulnerable period the patient is cared for with strict infection precautions, transfusions, and supportive treatment.

Preparation

Preparation includes completing the full evaluation, treating any infections and optimising general health and nutrition, arranging donor matching for an allogeneic transplant, and inserting a central intravenous line for treatment. Fertility preservation is discussed where relevant, since treatment can affect fertility.

Because the immune system will be severely weakened, careful planning of the environment and support is essential. If treatment is arranged abroad, plan for a long in-country stay covering conditioning, engraftment, and early recovery, and bring complete medical records.

Benefits and Expected Goals

The goal of a transplant is to restore healthy blood and immune function and to control or, for some conditions, cure the underlying disease. Allogeneic transplants can also provide an immune effect that helps fight some cancers, and for certain inherited disorders a transplant can be genuinely curative.

Benefits vary greatly with the diagnosis, disease stage, and match. Transplantation is intensive and carries real risks, and outcomes cannot be guaranteed. Your team can discuss the realistic chances of benefit and the risks for your specific situation.

Risks and Possible Complications

Bone marrow transplantation is intensive and carries serious, sometimes life-threatening risks.

• Severe infections during the period of low immunity
• Bleeding and the need for blood and platelet transfusions
• Graft-versus-host disease (in allogeneic transplants), where donor cells attack the recipient's tissues
• Organ damage from conditioning treatment, and effects on fertility
• Graft failure, relapse of the underlying disease, and long-term effects requiring ongoing monitoring

The transplant team will explain the risks specific to your type of transplant and disease and provide intensive support to prevent and treat complications. Report fever or any concerning symptoms immediately.

Recovery, Follow-up & Aftercare

Recovery is prolonged. The early phase, while the new marrow engrafts, usually means several weeks in or close to hospital with a very weakened immune system, needing transfusions and protection from infection. Immune recovery and return to normal life take many months.

Aftercare includes infection precautions, re-vaccination, and regular monitoring, and, for allogeneic recipients, careful watching and treatment for graft-versus-host disease, often with immunosuppressant medicines. Long-term follow-up is essential. Arrange this specialist follow-up with a haematology team at home before travelling back.

Medical Tourism Planning

If you are considering a bone marrow transplant abroad, choose a JCI- or ISO-accredited hospital with a recognised, accredited transplant programme (for example FACT or JACIE accreditation) and strong outcomes. Verify the team's experience with your specific disease and transplant type, and request a written treatment plan and cost estimate before you travel.

Plan for a long in-country stay covering conditioning, engraftment, and early recovery, and arrange long-term specialist follow-up at home. Be cautious of clinics offering unproven stem cell "therapies" outside established indications. Consider comprehensive medical travel insurance.

Estimated Cost Factors

Cost depends on the country and hospital, the type of transplant (allogeneic transplants are generally more complex and costly than autologous), donor search and collection, the conditioning treatment, the long hospital stay and intensive supportive care, and prolonged follow-up and medicines. Complications can add substantially to the total.

Costs vary widely by diagnosis and transplant type, and long-term care is a major expense. Prices quoted online are only estimates — always request a personalized written quote that clarifies exactly what is included before making any decision.

Choosing a Hospital or Specialist

Look for a hospital with recognised accreditation (JCI, ISO, or a strong national equivalent) and a dedicated, accredited stem cell transplant programme with published outcomes, experienced haematologists, and full supportive-care and intensive-care facilities. Confirm access to a reputable donor registry for allogeneic transplants.

Ask about the programme's survival and complication rates for your specific disease, international patient services, interpreter support, and how long-term follow-up would be coordinated with your home team. Transparent outcomes and written cost and treatment plans are essential signs of a quality programme.

Alternatives

Alternatives depend on the disease and may include chemotherapy, targeted and immunotherapy drugs, radiotherapy, and newer cellular therapies such as CAR T-cell treatment for some blood cancers. For some inherited disorders, ongoing supportive treatment (such as transfusions and medication) is an alternative to transplant.

Each option has different benefits, risks, and outcomes, and not all suit every diagnosis. Discuss all of them with your haematology team so the plan fits your disease, health, and circumstances. Be wary of unproven stem cell products marketed for conditions outside established evidence.

Questions to Ask Your Doctor

• Is a transplant the best option for my disease, and would it be autologous or allogeneic?
• Is the aim to control the disease or to cure it, and what are the realistic chances?
• What are this programme's survival and complication rates for my diagnosis?
• What are the specific risks, including graft-versus-host disease and infertility?
• How long will I need to stay near the centre, and what does recovery involve?
• How will long-term follow-up be coordinated with my team at home?
• What exactly is included in the cost estimate, including donor search and follow-up?